15 October 2011

RIL Results PAT 5703 Cr & GRM @ USD 10.10 per barrel (CNBC)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Mukesh Ambani group's flagship company Reliance Industries (RIL) second quarter results are in line with market expectations.
The company's Q2 net profit was up 15.8% at Rs 5703 crore versus Rs 4923 crore.
Its net sales were up 36% at Rs 78,569 crore versus Rs 57,479 crore.
According to CNBC-TV18 estimates, net profit was expected at Rs 5,750 crore and net sales were seen at Rs 79,800 crore.
The company's other income was up 63.99% at Rs 1,102 crore versus Rs 672 crore, YoY.
Its EPS was up 15.23% at Rs 17.40 versus Rs 15.10, YoY.
It petchem revenue was up 39.74% at Rs 21,100 crore versus Rs 15,100 crore, YoY
Its refining revenue was up 37.02% at Rs 68,100 crore versus Rs 49,700 crore, YoY.
Its Oil & Gas revenue was down 17.21% at Rs 3,560 crore versus Rs 4,300 crore, YoY.
Its gross refining margin at USD 10.10 per barrel.

Dhanlaxmi Bank,Exit on Rally:: ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


A I B O C   a l l e g a t i o n s   l e a d   t o  s t o c k   t a n k i n g   1 0 % . . .
As per news reports, the All-India Bank Officers Confederation (AIBOC)
has submitted a memorandum to the RBI alleging that Dhanlaxmi Bank
has manipulated accounts and provisioning, has a mismatch in assetliability resources, maintains poor capital adequacy ratio and has huge
dependence on call money borrowing. It cautioned against higher NPA
and accused the bank of window dressing its books to inflate profits.
Dhanlaxmi’s management has rejected these allegations regarding them
as baseless. According to Bipin Kabra, CFO, “The union is getting
marginalised every year. Currently, less than 10% workers are in AIBOC.
Our current capital adequacy is at around 10%. We see non-performing
assets dropping every quarter”. Given the seriousness of these
allegations and no response from the RBI on the issue we are cautious
on the bank and would advise investors to avoid the stock. For
investors holding the stock we would recommend exiting the stock on
rallies.
ƒ Long-term asset funding through shorter duration liabilities…
We have analysed the maturity profile of Dhanlaxmi Bank’s assets and
liabilities (FY11 data) to ascertain if there is a mismatch. We infer that
while ~40% of advances and investments lie in the maturity bucket of
three years and above, only 2.5% of deposits and borrowings lie in
the same (refer Exhibit 1). This implies that even though bank’s assets
(especially advances) are heavily tilted towards longer term, it is being
financed through short-term liabilities, which is a cause for concern.
V a l u a t i o n
Even though the stock has corrected by ~10% in a single session, we are
cautious on it. The bank reported a dismal performance last quarter with
profits declining 43.6% YoY to | 3.4 crore. Despite an estimated business
growth of 35% CAGR and PAT growth of 59% CAGR over FY11-13E,
return ratios are expected to remain depressed with RoA at 0.3% and RoE
at 5.3% by FY13E. Moreover, the recent deferment of its capital raising
plan had also led to an overhang on the stock. However, in light of
AIBOC’s allegations we would recommend avoiding the stock until more
clarifications or facts materialise. We would advise investors already
holding the stock to exit on rallies.

Cement - September dispatches remain muted… , ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


September dispatches remain muted… 
Cement majors report ~3% YoY growth in dispatches, decline ~5% MoM
In September 2011, the major cement players reported an aggregate
dispatch growth of 3.4% YoY. However, the companies have shown a
mixed performance. ACC reported 9.5% YoY growth in dispatches during
the month on account of Chanda capacity expansion, Jaypee reported
~17% YoY growth in dispatches, Ambuja Cement reported muted ~3%
YoY growth while UltraTech reported ~2% YoY decline and Shree
cement reported ~9% YoY decline in dispatches.
On an MoM basis, UltraTech, ACC and Shree Cement reported ~8-14%
decline in dispatches while Ambuja and Jaypee reported muted ~2-3%
growth in dispatches. The dispatches were lower on a sequential basis on
account of a slowdown in construction activities due to monsoons.
In August 2011, overall industry dispatches grew ~6% YoY while it has
declined ~6% on an MoM basis as the offtakes were impacted by a
slowdown in construction activities due to monsoons.
All-India average cement price picked up by | 10 per bag MoM in Sep ‘11
All-India average cement price have increased by ~| 5-20 per bag in
September 2011 across all regions (except south). This  price increase
happened after the correction of ~| 40 per bag during May-August 2011.
The recovery in cement prices is due to expectations of pick up in cement
demand as the monsoon ends. In the north and central region, prices
have increased by ~| 10-20 per bag MoM while prices have sustained in
the southern region and remained flat MoM. We expect cement prices to
recover further in October 2011 on account of a pick-up in dispatches.
Industry outlook
[
We expect all-India cement consumption to remain muted and likely to
grow by ~6% YoY in FY12E as against long term average growth of ~9%
CAGR. Muted demand is mainly on account of key issues like rising cost
of capital, slowdown in government projects, delay in construction
activities due to issues in land acquisition & clearances, political
uncertainty in Andhra Pradesh and unavailability of key raw materials. The
utilisation rate is expected to decline to 76% in FY12E as the incremental
demand of 12.5 MT is likely to be negated by ~18 MT of capacity
additions. However, we expect the utilisation rate to start improving from
FY13E (79%) as the incremental demand (~20 MT) will keep pace with
effective capacity addition (~23 MT).



Industry outlook
We expect the all-India cement consumption to grow ~6% YoY in FY12E
as we expect demand from the housing and infrastructure segments to
remain under pressure on account of key issues like rising cost of capital,
land acquisition & clearances and unavailability of key raw materials like
coal to the manufacturing industry.  However, the overall demand would
be higher than in FY11 on the back of lower base and anticipation of
demand reviving post monsoon. The capacity utilisation rate is expected
to decline further to 76% in FY12E as incremental demand of 12.5 MT is
likely to be negated by ~18 MT of effective capacity additions during the
year.
We expect the utilisation rate to start improving from FY13E onwards as
the incremental demand of ~20 MT is likely to keep pace with effective
capacity addition of ~23 MT in FY13E. We expect the utilisation rate to be
at ~77% in FY13E as against ~76% in FY12E.
In FY11, the all-India cement consumption grew ~4% YoY as demand
remained muted during the year on account of a slowdown in
construction activities, both in the infrastructure and residential segments,
mainly due to rising cost of capital, longer-than-expected monsoon during
the year, political uncertainty in Andhra Pradesh (the largest cement
consuming state in the southern region), Gujjar agitation in Rajasthan and
unavailability of sand and shortage of railway wagons to dispatch the
commodity on schedule. The capacity utilisation rate declined to ~77% in
FY11 from ~87% in FY10 on account of addition of ~44 MT of effective
capacity in FY11 as against incremental demand of ~9 MT during the
period.

C&S Industry - Update ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


L i g h t   f o r   C & S   i n d u s t r y…
The Cabinet Committee for Economic Affairs (CCEA) has cleared the
ordinance to amend Section 4A of the Cable TV Act, which implies that
the rules to digitise TV broadcast completely will be enabled. Currently,
the sunset date for analogue cable  is March 31, 2012 for four metros,
March 31, 2013 for the cities with  excess of 1 million population and
March 31, 2014 for all other areas in the country. In the latest guidelines,
these deadlines are expected to be postponed by three to six months
while the FDI cap for the cable and satellite (C&S) distribution industry is
expected to be raised from 49% to 74%.

ƒ Impact on MSOs, LCOs
For complete digitisation to take place, the MSOs will have to make
investments up to | 10,000 crore  for the installation of digital
equipment. Accounting for the subsidy to be provided on the set top
box, the investment required would go up to | 25,000 crore. Once
revenue leakages are plugged, MSOs are expected to witness a 4-5x
revenue jump.
The LCOs, on the other hand, will lose a huge amount of revenues,
which they would otherwise earn due to underreporting of
subscribers. Currently, ~80% of subscribers are under reported.
ƒ Impact on DTH industry
Mandatory digitisation will provide ample opportunity to the DTH
industry to increase its subscriber base. Currently, 70% of the Indian
C&S household, which accounts for ~68 million subscribers,
subscribe to analogue TV. These households will have to choose
before the sunset date to go for either DTH or digital cable
connection. The DTH industry is relatively well funded and has the
distribution infrastructure in place. Hence, it is better placed to
capitalise on this opportunity. We expect the DTH industry to speed
up the subscriber addition aided by the festive season as well. Dish
TV, being the market leader, would be the major beneficiary of this
development.
ƒ Impact on broadcasters
The subscription revenues of broadcasters are expected to increase
as underreporting of subscribers will be eliminated completely.
Also, the excess capacity of the digital mode would mean lesser
carriage and placement fees, which currently accounts for 20% of
the broadcasters costs.
Overall, this move is expected to be positive for all players in the C&S
industry including the government as  they will collect more taxes due to
prevention of underreporting of subscribers. However, we remain
sceptical about the industry meeting the deadlines of the sunset clause.
For Dish TV, we maintain our DCF target price of | 86, assuming revenue
CAGR of 20.0% over FY11-20 and a terminal growth of 4.5% thereon. We
recommend a HOLD rating on Dish TV.

Asia Macro and Strategy Outlook - Could Asia Be a “Safe Haven”? ::Citi Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 Asia is a “relative” safe haven given growth resilience vs DM – We see no
regional “decoupling”, but no China hard landing either — Deteriorating global
growth prospects will likely hurt more export-dependent economies but the
domestic-driven economies of Indonesia, India and China should fare relatively well.
 We think hard-landing fears in China are exaggerated – 1) the credit problems
do not look systemic, leading to widespread defaults; 2) We expect headline
inflation to ease noticeably by 4Q 2011, which will give China room for some policy
easing towards year-end; 3) China has significant fiscal flexibility in its central
government balance sheet, access to fiscal and public sector assets and negative
real rates that should make the overall debt burden manageable; 4) Related to the
first three, not all credit-funded investment is an immediate loss – we think
regulatory forbearance and financial repression (e.g. encouraging some refinancing)
will give China room to amortize losses over time.
 But room for countercyclical policy response is more limited than before —
With a less steep decline in commodity prices, stickier inflation expectations and
lower nominal rates to begin with for most, the ability to ease monetary policy is
more limited than in 2008. We expect Singapore, Indonesia (for sterilization cost
reasons) and Malaysia may be the most inclined to ease monetary policy. While
there is room for counter-cyclical fiscal policy in most of the region except South
Asia, we think China has much less room for credit-fueled infrastructure stimulus
executed by the local government than in 2008, and will resort to more central
government-funded fiscal stimulus, with possibly a lower multiplier effect.
 Asia cannot be a “safe haven” from financial linkages — We remain cautious
on risk sentiment, with our FX strategists calling for continued dollar rebound (DXY
at 80.8 in 3M). Outside of CNY (spot), where we expect gradual appreciation, we
don’t think any other Asian currency is a “safe haven’. Vulnerability of Asia FX could
lead to further real money redemptions of local bond portfolios, but we expect
redemptions to be temporary and should reverse once global risk stabilizes.
 We assess expected Asia FX based on FX reserve ammunition and
willingness to use it — We find that MYR screens weakest in Asia and CNY
screens the strongest. While we remain biased to be long USDAsiaFX on dips given
our bullish USD house view in the interim, on an intra-Asia basis we are biased to
be long CNY and SGD, while short MYR, TWD and possibly KRW (at better levels).

Buy Infosys, Target : Rs 2950 :ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


S h i b u ’ s   g e t t i n g   I n f y ’ s   a c t   t o g e t h e r …
Infosys executed one of its controlled earnings call in recent history and
reported Q2FY12 numbers, which were ahead of our and consensus
estimates. Sequentially, US$ revenues grew 4.5% (4.1% estimate) while
rupee revenues grew 8.2% (6.5% estimate) helped in part by the
depreciating rupee. Raising of FY12E EPS guidance to ~| 143.02-145.26
vs. | 128.2-130.08 was a positive surprise (they had done this before,
refer Exhibit 1) while lowering of FY12E US$ revenue growth guidance to
17.1-19.1% (18-20% earlier) was in  line with our expectation. We are
raising our FY12E estimates to accommodate the Q2FY12 beat and our
price target to | 2950 (| 2800 earlier) while maintaining our BUY rating.
ƒ Is the buffer in place for FY12E EPS guidance?
Concerns rose when Infosys raised the lower end of its FY12 EPS
guidance by 11.6% to | 143.02 vs. | 128.2 earlier to account for the
10% depreciation of rupee assumption in its guidance. However, we
would like to highlight that on July 11, 2008 (Q1FY09 earnings call),
Infosys had raised its FY09 EPS guidance by 7.6% vs. that given at
end of Q4FY08 led primarily by 7.6% depreciation of the rupee.
Note, during Q2FY09 earnings (October 10, 2009) Infosys
maintained its top end of FY09 EPS guidance despite 9.1%
depreciation of the rupee assumption in its guidance to | 46.97 vs. |
43.04 at the end of Q1FY09. The rationale could be the Lehman
bankruptcy filling on September 15. Finally, Infosys ended FY09 with
EPS of | 102.7 as CY08 IT budget spending remained fairly intact


V a l u a t i o n
We are raising our FY12E revenue/EPS estimates to | 33,851/| 139,
23%/16% YoY growth, respectively, while maintaining our FY13
estimates. We have valued Infosys  at 20x (19x earlier) our FY13E EPS
estimate of | 147.9 and maintained our BUY rating with a 12 month price
target of | 2950

Buy Escorts; Target : Rs 91 ::ICICI Securities

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


S p a n i s  h   t i e - u p   t o   im p r o v e   r a i lw a y   r e v e n u e s …
Farm equipment and engineering goods manufacturer Escorts,
announced that it has signed an exclusive agreement with Spanish firm
“Ingeteam Traction” to provide traction systems to Indian Railways.
Ingeteam Traction designs and supplies complete traction, control and
auxiliary systems for trams, EMUs, locomotives and high-speed trains.
The agreement with Ingeteam enables Escorts to foray in the niche
domain of rail traction systems. Ingeteam is a market leader specializing
in electrical engineering and serves key sectors like rail traction, marine.

Railway segment to provide additional revenue streams
The Indian railways inline with its  vision 2020 has sought technological
upgradation in various traction systems. Escorts will initially supply
traction control converter and locomotive control converter with design
and manufacturing of internal traction systems for rolling stock. The
product has large-scale application on electric locomotives, diesel-electric
locomotives, diesel electrical multiple units (DEMU) and electric multiple
units of Indian Railways. The traction systems can also be used on metro
rail coaches. The tie-up with Escorts marks the foray of Ingeteam into
India, to be a part of the large scale expansion plans of the Indian
railways, providing open and first technological level solutions.
Pick up in tractor volumes
Escorts sold 63,870 units in SY11 recording a modest 6.3% YoY growth.
Volumes for Q4SY11 advanced to 15,266 (up 7.4% QoQ) which could
have been bettered if not for the company’s limited presence in the
robust southern & western regions. Competitors like M&M, John Deere
and  TAFE  have  higher  penetration  in  these  areas.    However,  in  the
coming fiscals we expect the company to improve performance in these
geographies aided by flexible priority sector lending rates.
V a l u a t i o n
 We have factored market share pressures emanating from increasing
competition and slow operational turnaround. The stock is trading at | 80,
4.8x SY13E EPS. We have valued it on an SOTP basis with a target price
of  |  91.  We  are  giving  a  BUY  rating  on  the  stock  with  a  14%  upside
potential. We suggest investors who entered  at  higher  levels  to  hold  the
stock, recommend waiting for Q4SY11E results to make fresh entry

Cement - Sept growth muted at 4% y/y for the majors; quarter profitability very weak ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 Sept dispatches weak: Despatches reported by the 4 large players-
ACC, ACEM, UTCEM and JPA (NR), stood at 7.39MT, down 5% m/m
but up 4.4% y/y. The sequential decline is surprising given that rains had
reduced from August, highlighting our view that demand recovery
remains tepid on the ground. Players with exposure to North/Central
India like Ambuja and Jaypee reported sequential growth of 2-3%, while
ACC and UTCEM volumes declined 8% and 10% respectively. While
y/y comparison during monsoon is difficult as it can vary depending on
the rainfall in that particular month, ACC and Jaypee continued to gain
market share with YTD growth in despatches of 15.3% and 9.3%,
respectively. UTCEM and ACEM continue to lag the overall industry
performance with YTD growth flat and +3% respectively versus Big 4
despatches growth of 5.5%.
 Prices improve in anticipation of demand: After the decline in prices
in most markets during the monsoon (South India witnessed modest
decline versus other regions), prices started to improve during Sept.
Prices have increased sharply in September in North and Central India
(up nearly 9-12% during the month), which witnessed large declines
during Jun-Aug. However, pricing increase in West India market has
lagged neighboring North India market, given concerns on the supply
from the oversupplied AP market. Our dealer checks indicate that
demand is yet to return, post the rains the price increase is partly driven
by lower supply and also by anticipation of improvement in demand post
the monsoon and festivals.
 Cement earnings preview- Sept a very weak quarter: Sep quarter is
seasonally weak given the impact from monsoon on despatches and
prices. Cement players would see cost escalation from full impact of
higher domestic coal prices and freight (driven by the diesel price hike in
end-June). Cement prices, we estimate, declined by 7-8% across
North/Central and Eastern India while broadly remaining flat in South
India. Hence while EBITDA/MT should be higher on y/y level (given
absolute level of prices were higher y/y), q/q decline is likely to be
material.

India Strategy DMF Flows (September-11): Another Month of Equity Inflows ::Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Strategy
DMF Flows (September-11):
Another Month of Equity
Inflows
Equity funds report inflows while fixed income
funds report outflows: During September, equity
funds reported inflows (of Rs15bn) for the second
successive month. Year-to-date, equity fund flows have
been positive in 6 out of nine months. Fixed income
funds, on the other hand, reported outflows (at
Rs564bn). Flows in liquid and income funds continued to
be negative (at Rs411bn and Rs153bn) during the
month. On the aggregate, domestic mutual funds
experienced outflows (at Rs549bn) for second month
running. At the end of September, the industry assets
stood at US$135bn, down 12.3% MoM.
Equity funds: In 2011 thus far, inflows in equity funds
have aggregated to Rs77bn as compared with outflows
of Rs136bn for the same period in 2010. By end of the
month, the equity assets under management declined
5.2% MoM – at US$39bn – lowest level since July-09.
The share of domestic equity assets to market cap rose
to a 13-month high at 3.2%.
Fixed-income funds: In 2011 thus far, inflows in fixed
income funds aggregated to Rs261bn as compared with
outflows of Rs462bn for the same period in 2010. During
2011, liquid funds reported inflows of Rs299bn while
income funds reported outflows of Rs38bn, respectively.
By end of month, fixed income assets fell to a 6-month
low at US$96 billion – down 15% MoM.
Monthly Fund Tracker: Assets of gold funds made
another high at Rs82bn in September. In 2011, AUM for
liquid and gold funds is up 45% and 132%, respectively.
Sector Trends: SEBI data suggests (till August) that
since the start of 2011, AUMs for Consumer Staples and
Telecoms have risen the most while they have fallen the
most for Industrials. During August, AUMs for Energy
rose the most while Financials saw the biggest fall.

India Oil & Gas, Chemicals Feedstock: Refining margins - holding up well for now ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Refining margins have remained quite robust, even in the face of an
expected economic slowdown.With recent newsflow regarding the
upbeat expectations for Libyan production ramp-up and Iraqi
production, we take a look at changing dynamics for GRMs.
 Positive Libyan newsflow weighs on light-heavy differntials: Upbeat
newsflow on Libyan production ramping up swiftly to 1.3mbopd by the
end of 2012 has raised expectations of availability of light sweet crude
for refiners. This, coupled with slowing economic growth is likely to
result in predominantly sour crude being cut back.
 Refinery shutdowns/start-ups to cause an impact too: Per our
commodities team, an estimated 900kbopd of refining capacity is
expected to be shut down across the US/EU in 2012, while 810kbopd of
largely complex capacity is expected to start up in Asia - this will cause a
narrowing of light-heavy differentials as well.
 But near–term Brent/Dubai could rise: Brent-Dubai differentials have
seen a sharp correction since the Libyan news broke. Given uncertainty
over whether Libya can actually ramp production up as quickly as stated,
continuing North Sea production issues and the correction already seen,
in the near-term, Brent/Dubai spreads could see a tick up - positive for
complex refiners.
 Fuel oil has aided Singapore margins: Another factor that has aided
robust GRMs, even while diesel spreads have moderated from their post-
Japan highs has been fuel oil - strong performance in this product has
seen the premium earned by complex refiners over Singapore
benchmarks decline (as those refiners produce little or no fuel oil).
 Margin watch: Benchmark GRMs remained firm, averaging $8.13/bbl
this quarter (vs. $7.49/bbl in 1Q12). Diesel spreads have corrected to
$17.6/bbl (from $19.6/bbl), while fuel oil losses have improved to
$8.1/bbl (vs. $12.1/bbl).
 Fuel marketing watch: While crude has come off over the past few
weeks, depreciation in the INR has offset a portion of the gains. Diesel
losses stand at Rs8.2/lt over the last fortnight vs. Rs7.8/lt a month ago.
Petrochemical spread watch: Polyester-Naphtha spreads have remained
more robust than anticipated, at $1228/MT for the Sep quarter (vs.
$1145/MT in Jun quarter). Continuing tightness in the MEG market has
seen MEG-Ethylene at $595/MT in Sep quarter (vs. $404/MT in Jun).

Gold traders turn most bullish in 3 months after rout:: ET

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Gold's biggest slump in three years means traders are now the most bullish in three months, speculating that Europe's debt crisis, slowing growth and a bear market in equities will drive demand for bullion. 

Twenty-two of 25 people surveyed by Bloomberg expect the metal to rise next week, the highest proportion since mid-July . Prices rebounded 8.3% since reaching a two-month low at the end of September and investors are adding to their holdings in gold-backed ETFs for the first time in a month. 

Traders also expect gains in copper, sugar, corn and soyabeans, surveys show. Gold slumped as much as 20% since reaching a record $1,923.70 an ounce on September 6 as investors sold the metal to cover losses in other markets. 

As much as $4.2 trillion was erased from the value of global equities in the past month on mounting concern that economies will tip back into recession and European lawmakers will fail to prevent sovereign defaults. The last time traders and analysts were this bullish, bullion surged 21% to an all-time high within eight weeks. 

"There's macro-economic , systemic and monetary risk in the world and there's no sign of that going away any time soon," said Mark O'Byrne , the Dublin-based executive director of GoldCore, a brokerage handling everything from quarter- ounce British Sovereigns to one-kg (2.2-pound ) bars. 

"All the factors that drove gold to a record are still there." Gold advanced 17% this year to $1,667.70 by 1:07 am in New York, heading for an 11th consecutive annual advance. It's the thirdbest performer behind gasoil and Brent crude in the Standard & Poor's GSCI Index of 24 commodities , which fell 1.2%. 

The MSCI All-Country World Index of equities dropped 10% and Treasuries returned 7.7%, according to a Bank of America Corp index. Bullion dropped 11% in September , the most since October 2008. That spurred speculators in US futures to cut their net-long position, or bets on higher prices , to the lowest since February by October 4, according to data from the Commodity Futures Trading Commission. 

They held a net 127,249 futures and options, 13% below the average over the past five years. Investors reduced their holdings in goldbacked ETPs by almost 17 tonne last month, data compiled by Bloomberg show. They added 8.7 tonne so far this week, taking combined assets to almost 2,219 tonne, more than the holdings of all but four central banks. 


Those central banks are also accelerating their purchases. Thailand , Bolivia and Tajikistan bought a combined 18.2 tonne in August, IMF data show. The slump in prices means more buying for reserves is "very likely," according to Edel Tully, a London-based analyst at UBS. 

Central banks are adding to their holdings for a third year, the longest expansion in almost four decades. Raw sugar climbed 7% this week and white sugar 4.7% on speculation that flooding in Thailand, the world's secondlargest shipper, may delay harvests at a time when mills in top producer Brazil are ending their season early. 

The Thai sugar harvest may be delayed by two weeks, according to Newedge Group. Mills in Brazil's Sao Paulo state, which accounts for more than 50% of the nation's cane production, started shutting for the season in late September, the earliest in 12 years, because of a smaller crop, according to Celso Junqueira Franco, president of the Union of Biofuel Producers. 

Fourteen of 28 people surveyed expect corn to rise next week and 19 of 27 anticipate the same thing for soyabeans. Prices for both crops plunged by the most in at least three years last month on prospects for improving harvests . Both commodities rose the most in a year or more on October 11 on the Chicago Board of Trade as traders speculated that declines in September would boost purchases by makers of food, animal feed and biofuels. 

"Commodity markets are in the process of bottoming out and I think it may take a little time, maybe a few months, to solidify that bottom," said James Paulsen , the chief investment strategist at Wells Capital Management , which oversees about $360 billion of assets. 

Gold is shining after a break: 

Gold prices rebounded 8.3% since reaching a two-month low at the end of September and investors are adding to their holdings in gold-backed exchange-traded products for the first time in a month The metal rose 17% this year. 

It's the third-best performer behind gasoil and Brent crude in the Standard & Poor's GSCI Index of 24 commodities Central banks are also accelerating their purchases. Thailand , Bolivia and Tajikistan bought a combined 18.2 tonne gold in August.

Buy AUSTIN ENGINEERING - BENEFICIARY OF SURGE IN DEMAND :Sunidhi

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Company Description:
Incorporated in Junagadh, Gujarat in 1978, Austin Engineering Company (AECL) went public in 1985. It manufactures all kinds of bearings − ball bearings, tapered roller bearings, cylindrical roller bearings, spherical roller bearings, needle roller bearings, etc. Austin came out with a rights issue in 1992 to meet the cost of expansion and to augment long-term working capital requirements.
Products:
The range of bearings includes Ball Bearings, Cylindrical Roller Bearings, Needle Roller Bearings, Tapered Roller Bearings, Spherical Roller Bearings and Flexible Roller Bearings. AECL offers more than 4000 different types of bearings and are used in several industrial segments. The company has developed stainless steel (Grade 440C) bearings (for Atomic Energy Plant). AEL is among few manufacturers in the world to produce SPB’s 1200 mm diameter bearings.
User Industries & Clients:
The bearings offered by AECL find extensive application in the industries like Automobiles, Defence, mining, State Road Transport Corporations, Railways, Steel Plans, Thermal Plants, Turbines, Oilfield, Cement, Sugar, Textile Machinery, Paper Industry, Fan, Pump industry and Material Handling Equipment.
Its major clients are OEMs like Tata Motors, Premier Ltd, Bhilai Steel Plant, BHEL, Punjab Tractors, Baja Auto and Defence among others.
Quality:
AECL has ISO-9001 certificate from Rhineland/Berlin-Brandenburg Group of companies for design and manufacturing of Ball, Roller and Needle Bearings.
AEL also holds ISO/TS 16949:2002 certification from IATF's (International Automotive Task Force) for quality management system.
Exports:
AECL restricts its exports domain only to the most quality conscious markets like USA and Europe which accounts for about 50% of its revenues. It has set up 100% subsidiaries in USA and Italy, which also act as marketing front-end. It exports its products to Italy, USA, Germany and the UK.


During FY11, consolidated sales advanced buy 21.8% to `83.4 crore but net profit fell by 1.6% to `6.1 crore. Consolidated EPS stood at `18.0. OP and NP margin stood at 13.8% and 7.6% against 1% and 9.3% respectively in the corresponding period last year.
During Q1FY12, consolidated sales rose 55.3% to `26.4 crore and net profit by 109% to `2.3 crore. OPM and NPM stood at 15.9% and 8.7% compared to 12.4% and 6.5% respectively in the corresponding period last year. Q1FY12 consolidated EPS stands at `6.6.
Prospects
The `8, 000 crore bearings sector in India is expected to witness a smooth ride. Imports (inclusive of duties) account for over 45% of this demand. The user industries like automobiles, auto ancillaries, railways, steel, power and other industrial sectors are witnessing steady growth in demand, both from the domestic and export markets.
As a result of the rising demand from automobile industry the ball bearings prices were able to remain steady. With many auto majors in expansion mode the demand of bearings would only increase.
India's automotive sector is buoyed by continued growth in the economy, new launches of next generation platforms planned by various OEMs which will expand the size of the market, opportunities for exports both for finished automobiles and auto components.
Infrastructure spending in the 12th Five Year Plan is expected to double to US$ 1 trillion and these investments in roads, railways and power generation will result in a multiplier effect across the core sectors. Overall prospects for industrial development remain positive and therefore the strong demand for bearing products is expected to be sustained in the coming years. Furthermore as a result on account of economic development there is a healthy demand seen in the Industries like railways, engineering etc which augurs well for the bearings segment.
Growth Drivers
A steady growth in educated young population in India, expansion of middle class and effects of overall prosperity in rural areas are good indicators of inclusive economic growth. The need for effective and efficient transportation both personal and public will rise more rapidly than before. At the same time, the 'value consciousness' of Indian middle class will mean that market growth will be mainly focused in areas of motorcycles and small cars at least during the medium term.
Outlook
AEL has benefited from the surge in demand from the automotive sector and has improved its capacity utilization to keep pace with the growth in demand. So far, the growth has been lukewarm in other manufacturing sectors, too. Rebound in the capital goods sector and increase segment can get a push by good southwest monsoon, which will spur demand from rural areas and later on by possible easing of interest rates as the interest-rate hike cycle is coming close to its peak with the last 25 basis point hike.
AEL is expected to do well as offtakes from the motor cycle segment, the replacement market and exports are showing signs improvement. The demand of bearings in non-auto segments is also increasing at a faster rate.
Valuation & Recommendation
With full array, AECL offers high quality and precision bearings for different applications. AECL continues to launch a numbers of new and higher value added products, which will further strengthen the competitiveness in the future. AECL is continuously undertaking a comprehensive technology upgradation.
AEL is expected to post consolidated EPS of `23.4 in FY12. At the CMP of `75, the share is trading at a P/E of 3.2. We recommend BUY with a target price of `105 at which the share will trade at P/E of 4.5.

India Oil & Gas ; 2Q FY12F results preview ::Nomura research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

India Oil &Gas
2Q FY12F results preview
Likely another dismal quarter; muted q-q growth; OMCs may bleed again

Oil and petchem prices moderate, refining margins stay firm
Oil prices remained range-bound during the quarter before coming off
towards the end, owing to increasing global macro concerns. Brent prices
were down 4% q-q in 2Q. Singapore complex refining margins firmed up in
Aug/Sept after consecutive months of decline in June/July (overall up 5%
q-q), on strengthening gasoline cracks. After a sharp run-up last year, key
petchem prices and margins have seen some correction in the past few
months. Sharp rupee depreciation towards the end of the quarter (rupee
down 10% q-q on exit) was a key highlight of 2Q.
No respite for OMCs – Likely hit from large U/Rs, inventory/FE losses
Post the fuel price hikes and duty cuts in June 2011, gross underrecoveries
are likely to decline by ~50% q-q, in our view, but these still
remain high. Likely sharing remains unclear and a concern. We assume
33% / 50% sharing by upstream / government. However, if the government
delays or provides lesser support (34% in 1QFY12, we assume 50% for
2Q), OMCs could once again report losses (similar to 1Q).
We expect dismal 2Q results
Despite an improvement in regional refining margins, we expect RIL to
report muted growth (up 1% q-q). After five consecutive quarters of
sequential PAT growth, Cairn India is likely to report a sharp 81% q-q
decline in PAT in 2Q due to cost-recoveries on royalty and resulting one-off
provisions (our est. INR17.3bn). Gas volumes are likely to remain flat q-q
and we do not expect any big surprises in gas companies’ earnings q-q,
aside from IGL, where we expect 28% y-y and 6% q-q growth.

BUY Corporation Bank - Superior Return Ratio demands Valuation ::KJMC

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


South based Corporation Bank (CRPBK IN) is a mid sized state owned government
bank (GoI holding 58.5%) with a network of 1362 branches and balance sheet size
of Rs 1.4trillion. Having its dominant presence in Southern parts of India with
more than 50% branches, bank is trying to diversify its geographical distribution by
adding 150 branches in FY12 particularly in Western and Northern parts; has added
206 branches in FY11. We like Corporation Bank due to its aggressive branch
addition, enjoying best asset quality in class & robust business mix growth. With
all the banks facing interest rate pressure, NIMs of the bank will also be under
pressure in FY12 which has been factored in its current price.
At CMP of 415, the bank is trading at an attractive valuation of 0.7x FY13E ABV. We
initiate coverage on Corporation bank with “BUY” rating with a price target of Rs
601 (i.e. discounting FY13E by 1.0x, an upside of 45% from current levels).
Key Highlights
Robust business mix growth: CRPBK has been very aggressive in growing its business
mix with advances growing by 30% CAGR over FY08‐11 way above industry levels.
Although, trend doesn’t seems to continue in FY12 due to rising interest rate regime.
Thus, we have assumed 22% YoY growth in its advances in FY12E which we assume
as lowest assumption looking at the last five years growth in advances. Currently,
bank has crossed its business mix of Rs 2trillion and going forward it is expected to be
at Rs 2.5 trillion in FY12E.
Aggressive branch addition to continue in FY12: In comparison with its peer group,
bank has added highest number of 206 branches in FY11. Currently, it has around
1362branches and is expected to add another 150 branches against management
guidance of 200 branches in FY12E which will be used to draw CASA in the longer
run.
Asset Quality best in class: Gross NPAs of the bank stood at 1.1% which is considered
to be best in class as compared to its peers. However, it is expected to rise marginally
to 1.2% in FY12 due to slowdown in the economy.
Superior return ratios demand Valuation: CRPBK has been consistent in delivering
strong RoANW and RoAA above 20% and 1% respectively in last two years. In FY11,
RoE and RoA stood at 21.9% and 1.1% respectively reflecting its strong performance
in the bottom line. However, we expect decline in both RoANW and RoA in FY12 to
19.1% and 0.9% due to higher interest cost impacting bottom line which will improve
back in FY13 to 21.3% and 1% respectively.

Pharma 2Q Preview – Last Modest Quarter Before Earnings Ramp:: Morgan Stanley Research

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Pharmaceuticals
2Q Preview – Last Modest
Quarter Before Earnings
Ramp
Quick Comment – We expect F2Q12 results to be
unexciting, on lack of major product launches (esp in the
US) and tough comps (Ranb’s forex income, Sun’s
residual Eloxatin etc last year). We estimate 11%, 13%
and (9.5)% sales, operating profits and net profit yoy
growth for the sector for 2Q. Excluding Ranb, we expect
12%, 13% and 5% growth, respectively. From here on,
we expect meaningful sequential improvement in sector
earnings in ensuing quarters, driven by new launches
(Zyprexa, Lipitor subject to FDA clearance, Seroquel,
Plavix, Geodon, OCs, fonda ramp up etc), some
operating leverage (such as scale up in Cipla’s Indore
SEZ) and forex benefits (lower INR versus USD).
Company wise commentary – Sun should benefit from
continuing improvement in Taro and Cipla should benefit
from Indore SEZ and forex (low hedging policy). We
expect modest quarter from Lupin (ex Medicis payment),
Glaxo (domestic market slowdown) and DRRD (poor
fonda ramp up in US, 10% market share). Biocon will
report off a high base due to Axicorp exclusion.
What to watch out for – 1) Ranb’s comments on
FDA/DoJ resolution and Lipitor launch prospects. Given
the absence of ftfs, Ranb results should give perspective
on the strength of its base business. 2) Sun’s execution
on its lofty 28-30% sales growth guidance for F12. 3)
Cipla’s scale up of Indore SEZ and EU inhaler update. 4)
DRRD’s progress in EMs (esp India and Russia), US
pipeline and F13 guidance. 5) While INR has sharply
depreciated by 9.5% (versus USD) during the quarter to
Rs48.97; the AVERAGE qoq depreciation is just 2.4%
(Exhibit 9); implying that the real benefit of forex
(adjusted for hedges) will be felt in the Dec’11 quarter.
Our pecking order in the sector remains unchanged
– DRRD, Lupin, Sun and Ranb (all OW). We retain EW
on Cipla, GSK and Biocon. The sector is trading at 20x
and 16.5x F12 and F13 EPSe (20% EPS CAGR).

European Banks & The Grand Solution :: Stress Testing the Banks::Citi,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


European Banks & The Grand Solution
Stress Testing the Banks, Part 3
 Progress Towards Bank Recap — Work on a “comprehensive” solution to the
European sovereign crises appears to be gathering momentum. EC President
Barroso's speech yesterday highlighted a coordinated recap of the European banking
system as well as proposals to increase the EFSF’s firepower, accelerating the ESM to
2012 (from 2013), as well as more integrated economic governance.
 Stress Tests Part III — Mr. Barroso’s plan calls for banks to be recapitalised
“temporarily [to] significantly higher capital ratios of highest quality capital”; press
reports suggested that the benchmark for EBA stress tests could range at 7-9%. We
believe that the stress tests could also include sovereign exposures held within the
Banking book (not just the Trading book).
 €64-€216bn Core Capital Shortfall, or Less?— We estimate a core capital shortfall
for the EU banks included in the stress tests of €64-216bn, for a minimum CET1
requirement of 7-9% respectively; this represents c1-2% of GDP. Marking-to-market
(rather than stressing) sovereign exposure would reduce capital requirements by c€20-
40bn. Using the “baseline earnings” would represent a further c€150bn improvement.
 Raising Capital, Restricting Dividends — For banks with a shortfall, Mr. Barroso
proposes they first tap private sources of capital; followed by national government
support, backed by loans from the EFSF where necessary. We expect the widespread
involvement of public capital. Banks requiring public capital injections would face
temporary restrictions on dividends (and potentially on staff rewards).
 Devil in the Ddetail? — Hopes of a "comprehensive" solution to the eurozone crisis,
including bank recapitalisation, have been rewarded by equity markets in recent days.
However, the devil is in the detail and a lot is still unknown: the target capital level, the
type of capital (preference shares or common equity?); the timescale banks will be
afforded to raise their capital ratios, the extent of restrictions on dividend payments
(and T1/T2 capital coupons) and even more importantly, the nature and scale (end
effectiveness) of the liquidity backstop and EFSF firepower.
 Next Steps — The EU summit scheduled for 17-18 October has been pushed back to
23 October, ahead of the G-20 meetings on 3-4 November, to allow time to "finalise our
comprehensive strategy on the euro-area sovereign debt crisis” (EU President Van
Rompuy). The increasing anticipation is for Franco-German accord on bank
recapitalisation plans by the postponed summit.
 Don’t Forget The Sovereign — While a bank recap may provide additional confidence
to funding markets, we believe this is not an alternative to addressing the 'core' issue –
namely providing a credible sovereign liquidity backstop and, over time, creating an
integrated governance system for the EU to support the shift towards greater debt
sustainability.

Valuations reasonable but macro worries could remain an overhang in the short term ::Angel Broking,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Strategy
Valuations reasonable but macro worries
could remain an overhang in the short term
During 2QFY2012, Indian markets fell in tandem with peers
on heightened global macro concerns, registering their worst
quarterly performance since the 3QFY2009 fall following
the Lehman crisis. Uncertain global macro environment,
moderating domestic growth with persistently higher
inflation and concomitant policy rate hikes by the Reserve
Bank of India (RBI) have overshadowed the reasonable
valuations of domestic equities.
The key triggers for Indian equities are likely to be in the form
of a) peaking of the domestic inflation and interest rate cycle
and b) restoration of some degree of certainty in global markets
on the back of structural reforms in the Eurozone.
Hence, in the short term, Indian equities are likely to gyrate
depending on global cues, despite reasonable valuations.
However, over the longer term, we remain confident on
the long-term prospects of the Indian growth story due to
benefits of demographic dividend, a primarily internal
consumption-driven economy, better positioning vis-à-vis peers,
reasonable earnings growth trajectory and reasonable
valuations in the context of India's structurally positive outlook.
In the near term as well, cooling global commodity and energy
prices also bode well for the Indian economy and are likely to
lead to peaking out of the WPI inflation cycle in September
2011. Inflation is likely to see meaningful deceleration from
January 2012. As inflation peaks out, we expect the interest
rate cycle to peak out with expected policy rate cuts from CY2012
to stimulate the moderating domestic growth momentum.
Growth vs. inflation conundrum
In spite of slowing domestic growth, inflation has stubbornly
remained above the RBI's indicated comfort level of 5-5.5% for
21 consecutive months. In fact, headline WPI inflation in
August 2011 approached the double-digit mark at 9.8%. The
acceleration in core (non-food manufacturing) inflation in
August 2011 indicated the persistence of inflationary pressures,
which in the RBI's words has remained high, generalised and
much above its comfort zone.
Based on the historical relationship of WPI inflation with Reuters
CRB Index and considering the remaining pass-through of oil
and electricity prices, we believe inflation is likely to remain
closer to (or possibly above) the double-digit mark in September
as well as October 2011.
High inflation readings are likely to force the RBI to persevere
with its hawkish stance, considering the RBI's unequivocal
guidance of change in stance only if the inflation trajectory shows
a downward movement. Hence, we do not rule out further policy
rate hikes until December 2011. However, the recent sharp fall
in global commodity and energy prices following the Fed's
abstinence from adopting quantitative easing (QE)-III and
weaker global demand prospects are likely to aid in pulling
down headline inflation to at least the 8-9% band from
December 2011 and is likely to be a meaningful case for the
RBI to pause and even think of cuts depending on the domestic
growth scenario and international macro environment.
Global macro worries loom large, leading to risk
aversion among global investors
The recent economic news flow from both the sides of the Atlantic
has been disappointing. The Fed gave a stern warning in terms
of significant downside risks to growth and cautioned on the
financial market stress. Sovereign debt crisis concerns among
Eurozone countries remain unresolved and measures adopted
by policy makers seem to be focusing solely on the short-term
postponement of the problem rather than on a long-tem
resolution once and for all. However, the expanded bailout fund
(EFSF) is large enough, in our view, to avert a sudden financial
shock. The IMF also cautioned, in no uncertain words, that the
global economy is entering a 'new dangerous phase'.
Increased volatility and uncertainty across global markets, be it
equities or commodities, have led to risk aversion amongst
global investors, which has led to FIIs pulling out over US$2bn
from Indian equities and a 10.2% fall in the benchmark index
over the past two months.
2QFY2012 earnings likely to disappoint
Margin pressures have dented the profitability of Indian
corporates over the past few quarters and are likely to continue
in 2QFY2012 as well. While top-line growth for Sensex
companies is expected to remain healthy at 21.1% yoy
(muted 2.6% qoq), margin pressures are likely to result in PAT
growth falling to sub-10% (at 8.2%) level. However, on a
sequential basis, both operating and net profit margins are
expected to improve, albeit marginally. Earnings for Angel
coverage universe are expected to grow at 7.4% yoy, driven by
18.6% yoy top-line growth.

Trouble if you do, trouble if you don't - this is largely the story of "big" acquisitions in Indian IT ::JPMorgan,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 ‘Big’ acquisitions in Indian IT ordinarily have several objectives but there
are three most often articulated objectives: (a) introducing or raising growth
profile in a distinctive, altogether new function (vertical/horizontal/geography)
and (b) cross-synergizing with existing capabilities and selling into both
existing/acquisition-generated new clients to further boost acquirer’s organic
growth prospects and (c) achieving sufficient, scalable offshore flow-through
(or downstream) over time to breakeven on margins. (B) and (C) are typically
longer-term aims and much harder to realize as well.
 We find that most, if not all, large acquisitions fail tests (B) and/or (C).
High-profile acquisitions that have delivered below expectations in our view
include Info-crossing (acquired by Wipro in Aug-07 for USD 600 mn) and to a
lesser extent Axon (acquired by HCLT for USD 658 mn in Dec-08). Infocrossing
has not consolidated Wipro’s then existing leadership in inframanagement
(if anything TCS/HCLT have taken over leadership in inframanagement
in the last 2 years). Meanwhile, HCLT’s ability to leverage the
AXON acquisition to drive downstream at higher margins is doubtful (does not
meet objective (c)). Also, AXON has not helped HCLT grow enterprise
solutions (implementation of SAP/Oracle solutions) ahead of peers.
 Initial market reaction to significant acquisitions (during a defined time window
before/after the acquisition announcement) has generally been negative and in
most cases, rightly so. The market is especially skeptical of mergers between
companies especially of a company into a smaller/comparably sized one (e.g.
Patni-iGate or Tech Mahindra-Satyam). Tech Mahindra paid Rs ~59 per share
for stake in Satyam in April 2009. Two and half years later, the Satyam stock at
Rs 65 has returned ~11% (or annualized ~4% much below cost of equity and
very significantly below the IT index). From the time of announcement, the
economic break-even period for the investors (which includes cost of
equity) for significant mergers tends to be an extended one.
 We find that it could be a period of 12-18 months after the merger
announcement that value emerges for the investor. Investor interest in stocks
of companies involved in the merger emerges only at very reasonable valuations
when merger/acquisitions risks are more than adequately priced in. Such a point
may reach after a period of significant stock underperformance post the merger
announcement (e.g. Patni today is perceived by some investors as cheap).
 To sum up, we would temper buoyant expectations of significant acquisition(s).
The feel-good factor that prospect of a large acquisition sometimes induces may
be more psychological that does not square with the subsequent track record.
 TCS (OW) still our top pick in the sector. As per our detailed evaluation, in
recent memory, TCS’ e-Serve acquisition is the rare, significant big one in
Indian IT that has met all the three objectives. e-Serve now serves clients outside
Citigroup. In addition, e-Serve’s EBIT margins at 40%+ (FY11) is perhaps the
highest margins for the BPO sector (~ 2x Infosys’ BPO margins) (or 20% points
up from e-Serve’s margins of 20% at the time of acquisition). The consideration
value of 10x EBIT (on 2009) is now 3x EBIT (on 2011) signifying how much
TCS has extracted from this acquisition. In this report, we document TCS’
success at e-Serve as an exception among other case studies of relative failure.

Tata Chemicals – Evolving natural resource play ::RBS

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Tata Chemicals has been building cost efficiency through acquisitions and strategic expansions.
Cash flows from stable businesses – fertiliser, salt and agrochemicals – have helped offset those
from the cyclical soda ash. We initiate coverage with a Buy rating and target price of Rs380.


Recent ventures are aimed at strengthening cost competitiveness
TTCH’s recent acquisitions, such as British Salt and EPM Mining in the US and a minority stake
in Gabon urea plant, are aimed at building a low-cost base in the medium to long term. This
should help the company weather a downturn better, in our view. Even the company’s existing
operations and capacities are likely to be expanded in low-cost locations, such as the US for soda
ash and India for salt.
Global subsidiaries’ profitability has been trending up
Both GCIP (the US subsidiary) and Brunner Mond (the European subsidiary) have been
improving profitability driven by higher prices and cost rationalisation. We expect this trend to
continue in the near term. The company should benefit from proposed urea subsidy scheme due
to its high energy efficiency. Salt capacity expansion should also strengthen cash flows.
Forecasting lower debt and a 17% EPS CAGR in FY12-14; stock at a discount to peers
We expect soda ash price realisations to be flat in FY13/14 and operating rates to decline
marginally. We forecast free cash flow generation of Rs15bn annually, which should reduce net
gearing to 37% by FY13. ROE should also improve to 16% by FY13 from 14% in FY11. We value
TTCH using SOTP as it has many businesses. We value Tata Chemicals’ standalone chemicals
and US businesses at 5x FY13F EV/EBITDA—at par with global specialty chemicals companies
due to its low-cost advantage plus the presence of its domestic salt business. We value fertiliser
at 6.8x FY13F EV/EBITDA—at par with global peers —and UK business at 4.5x FY13F
EV/EBITDA—a 10% discount to global comps (as synthetic soda ash). Also, we value its Rallis
stake at a 20% holding company discount.
Key risk is an extended global slowdown
Historically, the price of soda ash has been less volatile than that of commodity chemicals, as
most sales are through long-term contracts. However, a protracted global slowdown, especially in
China, could create a surplus and depress prices and operating rates.

Tata Chemicals – Evolving natural resource play ::RBS

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Tata Chemicals has been building cost efficiency through acquisitions and strategic expansions.
Cash flows from stable businesses – fertiliser, salt and agrochemicals – have helped offset those
from the cyclical soda ash. We initiate coverage with a Buy rating and target price of Rs380.


Recent ventures are aimed at strengthening cost competitiveness
TTCH’s recent acquisitions, such as British Salt and EPM Mining in the US and a minority stake
in Gabon urea plant, are aimed at building a low-cost base in the medium to long term. This
should help the company weather a downturn better, in our view. Even the company’s existing
operations and capacities are likely to be expanded in low-cost locations, such as the US for soda
ash and India for salt.
Global subsidiaries’ profitability has been trending up
Both GCIP (the US subsidiary) and Brunner Mond (the European subsidiary) have been
improving profitability driven by higher prices and cost rationalisation. We expect this trend to
continue in the near term. The company should benefit from proposed urea subsidy scheme due
to its high energy efficiency. Salt capacity expansion should also strengthen cash flows.
Forecasting lower debt and a 17% EPS CAGR in FY12-14; stock at a discount to peers
We expect soda ash price realisations to be flat in FY13/14 and operating rates to decline
marginally. We forecast free cash flow generation of Rs15bn annually, which should reduce net
gearing to 37% by FY13. ROE should also improve to 16% by FY13 from 14% in FY11. We value
TTCH using SOTP as it has many businesses. We value Tata Chemicals’ standalone chemicals
and US businesses at 5x FY13F EV/EBITDA—at par with global specialty chemicals companies
due to its low-cost advantage plus the presence of its domestic salt business. We value fertiliser
at 6.8x FY13F EV/EBITDA—at par with global peers —and UK business at 4.5x FY13F
EV/EBITDA—a 10% discount to global comps (as synthetic soda ash). Also, we value its Rallis
stake at a 20% holding company discount.
Key risk is an extended global slowdown
Historically, the price of soda ash has been less volatile than that of commodity chemicals, as
most sales are through long-term contracts. However, a protracted global slowdown, especially in
China, could create a surplus and depress prices and operating rates.

Tata Motors : NDR takeaways from Europe ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


We hosted the senior management of Tata Motors in Europe last week. Please
find key takeaways:
 Management is upbeat on the ‘Evoque’: Management highlighted that the
Range Rover Evoque has received an encouraging response with prebookings
at 25,000 units already. They believe the product has a potential to
achieve annual sales of c.80K – 100,000 units.
 Scale up plans in China, MOU with a local partner: JLR has been a late
entrant in China and hence is currently scaling up the distribution network
there. Currently, they have c.80 dealers, which they intend to raise to c.100
in the near term. Management recently signed an non binding MOU with a
local Chinese manufacturer. Talks to set up manufacturing facility are at an
initial stage and it will take a while to sign off with the JV partner, obtain
regulatory approvals and set up facility to commence production.
 Developed market environment is uncertain: Management highlighted
that sales in Western Europe are weak; however the environment in the US
is currently stable and discounts are at normalized levels.
 Domestic business outlook is mixed: On the India business, they expect
strong sales growth for LCVs to sustain while growth rates for M/HCVs
will be modest. On the passenger segment, management is revamping the
distribution network of the Nano, which includes setting up dealerships in
rural India.
 Balance sheet: The company is well funded currently and intends to meet its
capex programs from internal accruals. They highlighted that the capex
programs are flexible (currently at GBP 1.5B p.a.) and could vary given
worsening in the external environment.
 Outlook: We believe that the management is cautiously optimistic on the
growth outlook. They have a well diversified product / geographic mix,
which will enable them to better withstand the current cycle. Please see our
earlier note:

Tata Motors:: Valuations factoring in a challenging environment, JLR well positioned in the current cycle, reiterate OW :JPMorgan

India Property: 3Q Data – Pass-through Quarter ::Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Property
Ears On The Ground 26: 3Q
Data – Pass-through Quarter
Quick Comment: Based on JLL REIS 3Q residential
data for the top 7 metro areas in India, the physical
market appears to be more or less stagnant and stable.
Higher property prices (15-30%) above 1Q08 peak
(lower in real terms), peak interest rates (11-12%
mortgage rate), and weakening sentiment has not yet
translated into a meaningful slowdown in property sales
in India (ex Mumbai and Noida). However, some slowing
in new launches could be indicative of early signs of
waning developer confidence. The highlight of the
quarter was the precipitous decline in Noida.
A look at the data (Exhibit 2): The top seven metros
areas (ex Noida) recorded new sales of 32.5k units
(sequentially flat). New launches (four years to construct
and deliver) were 30.3k units (-14% sequentially, last
four-quarter average of 44.4k units). Stable new sales,
but lower new launches, resulted in a marginal (1%)
uptick in the absorption rate to 15% (implying five-plus
quarters of unsold inventory). In the worst period (4Q08),
new sales were 14k units new launches were 17.4K
units and the absorption rate was 10%
By-City Commentary: Gurgaon was the stand-out
market with sustained new sales (6k units, in line with
four-quarter average) and the highest absorption rate
(24%). Bangalore, while maintaining its new sales
momentum (3.7k units), continues to see its absorption
rate fall (11%) due to high new launches. New sales
were low for Mumbai, Noida and Pune (versus history)
and for Kolkata and Hyderabad – Exhibit 12.
Now What: With a little equity and debt funding, firms
are becoming increasingly reliant on development
income to generate cash flows and de-leverage. As of
now, companies are showing little urgency to scale up
new sales targets. This means that the pace of
de-leveraging will be slow and ROEs will stay in single
digits. If GDP does decelarate and/or global macro
worsens, developers may have to cut prices. Maintain
OW on OBER, SDL, IBREL and EW on DLF, JIL, and
GPL.

Phrama: FDI: A giant in our backyard? :: GEPL

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


The Concern
The Health Ministry was deeply concerned with the recent spate of acquisitions/takeovers
taking place in the Indian pharmaceutical space. The Ministry believed that takeover of the
Indian Pharmaceutical companies by MNCs was a worrisome trend as it could lead to
increase in drug prices taking generic drugs out of the reach of common man.
Recent takeovers
Since 2006, several MNCs have taken over Indian Pharmaceutical companies:
Target Acquirer Date Value (approx)
Matrix Labs Mylan Inc (US) August, 2006 $736mn
Ranbaxy Laboratories Daiichi Sankyo (Japan) June, 2008 $4,600mn
Shantha Biotech Sanofi-Aventis (France) July, 2009 $783mn
Piramal Healthcare Abbott Laboratories (US) May, 2010 $3,700mn
Orchid Chemicals Hospira (US) December, 2009 $400mn
Dabur Pharma Fresenius Kabi (Singapore) May, 2008 $139mn
During the period April-July, 2011, Indian pharmaceutical sector received FDI worth $2.99bn
(`134.26bn). However, since 2001, when the sector was open for FDI, less than 10% of the
investment has gone into Greenfield investments.
Arun Maira Committee
Consequently, the Cabinet Committee on Economic Affairs (CCEA) set up a committee under
planning commission member, Arun Maira to study the effect of such takeovers on the
Indian pharmaceutical industry and to suggest measures for strengthening the sector.
Following were suggestions of the committee:
• To keep FDI policy in pharmaceutical sector unchanged and continue with 100% FDI in
pharmaceutical sector through the automatic route.
• Competition Commission of India (CCI) should be given more teeth to regulate M&A
activity in the sector.
• Lowering of threshold limit for deals needing CCI nod. Currently, most acquisitions fall
under group criteria for filing ($3bn for assets and $9bn for turnover).
Commerce Minister’s stand
Commerce Minister Mr. Anand Sharma sent out a strongly worded letter to the PM seeking
his intervention on the whole issue. He was critical of the lack of effective suggestions by
the Arun Maira committee. Mr. Sharma alleged that the takeover of Indian pharmaceutical
companies by MNC pharmaceutical companies was a deliberate attempt to weaken the rise
of Indian generics. He suggested that 100% FDI should be allowed in Greenfield projects and
M&A proposals should be routed through the Foreign Investment Promotion Board (FIPB).
Stalemate
• The Health and Commerce Ministries were in favor of the FIPB being the watch-dog
whereas the Maira Committee had suggested CCI for the job.
• Also, the Health Ministry and DIPP wanted the sectoral FDI limit reduced whereas the
Department of Pharmaceuticals and the Finance Ministry were opposed to any
clampdown.
• This difference of opinion led to a stalemate on the whole issue with the matter
remaining unresolved.


Intervention by the Prime Minister
Realizing that some policy stance was required on the issue, Prime Minister Dr. Manmohan
Singh called a meeting of the Union Ministers of Health, Commerce and Finance on 10th
October, 2011.
Following decisions were taken during the meeting:
• No cap on FDI in the pharmaceutical sector and 100% foreign investments allowed.
Impact: Helps to create and continue with image of India as an investment-friendly
destination.
• Greenfield investments continue to be allowed under the automatic route and no
scrutiny needed. However, acquisition proposals to be looked at very carefully by the
Government.
Impact: Would facilitate new technology developments, capacity expansion and
investments into the country. Domestic players would have to step up R&D efforts and
technological expertise to match their MNC peers, while retaining cost
competitiveness.
• Brownfield investments to be routed through FIPB approval route for six months. After
six months, the oversight will be done by CCI. Necessary steps to be taken to
strengthen the CCI to make it capable of overseeing the transactions.
Impact: The fast takeovers of Indian pharmaceutical companies by global majors posed
the danger of a few companies deciding price of drugs, thereby putting them beyond
reach of the common people. This is neither politically nor socially acceptable in India.
Giving more teeth to the CCI would help to ensure that drugs remain within the ambit
of the common man.
• The Government plans to set up a committee to help the CCI study the pharmaceuticals
sector and gain expertise in it; something which it currently lacks.
Comment
Whether it is the recent aggressive takeovers of Indian Pharmaceutical companies by MNC
giants or increasing partnerships with their Indian counterparts for marketing drugs in India
or ramping up of work force by MNCs in India, the writing on the wall is loud and clear: Big
Pharma is here to get us!! The big boys of the Pharmaceutical world are training their guns
on India, where they see an under-penetrated and untapped market. They are going all out
with their financial muscle and technological expertise.
It is true that cost-competitiveness, abundance of skilled manpower and strict adherence to
global norms have been the strength of domestic pharmaceutical companies till now.
However, even today, India lacks serious innovator companies as most of the domestic
companies seem to be content with bringing out me too products and copy cat drugs.
Already, the labor cost-effectiveness is reducing fast as wages have risen rapidly in India.
The recent spate of takeovers should sound an alarm bell for Indian pharmaceuticals. There
needs to be greater emphasis on Research and Development.
The Government might have saved the day for domestic companies for now. However, it
cannot be expected to step in every now and then as it too has a pro-investment image to
protect.

Motherson Sumi Systems SMFL files draft IPO document:: UBS


Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



UBS Investment Research
Motherson Sumi Systems
SMFL files draft IPO document
�� Event: SMFL files draft IPO prospectus with SEBI
Samvardhana Motherson Finance Ltd (SMFL) has filed a draft red herring
prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for an
IPO aggregating Rs17.5bn (new share issuance of Rs14.13 bn and Rs3.4bn stake
sale by promoter group company). SMFL has a 36.34% stake in Motherson Sumi
Systems (MSSL), 49% in Samvardhana Motherson Reflectec (SMR), and is
present in other businesses.
�� Impact: proposed capital raising in SMFL could support capex, lower debt
MSSL, which has businesses partly similar to SMFL, is currently trading at a
trailing PE of 17.3x FY11. SMFL consolidated restated net profit was Rs1.4bn in
2011, as per the DRHP. Capital raising in SMFL could support capex and lower
debt for its subsidiaries SMR and Peguform (acquisition under process). Group
structure continues to be complex due to cross-holdings and could impact investor
sentiment, in our view.
�� Action: good management track record, SMR/Peguform scale-up
We maintain our Buy rating with a price target of Rs280. Our positive stance is
premised on management track record, historical capital discipline, high return
ratios, and scale-up potential of SMR and Peguform. The MSSL stock is trading at
an FY12/13E PE of 14.3x/11.0x. Key risks are a global recession, Europe macro
risks, and the outcome of any proposed group capital-raising activity, which could
impact investor sentiment on the stock.
�� Valuation: maintain Buy rating with Rs280 price target
We derive our price target from a DCF-based methodology and explicitly forecast
long-term valuation drivers using UBS’s VCAM tool. We assume a 12.0% WACC



See full list -click link below:

UBS Mid-Caps Strategy - What to Buy? �� Oct 2011 Update